Projects per year
Fingerprint
- 1 Similar Profiles
Collaborations and top research areas from the last five years
-
ANI395: CARGO: advancing chimeric antigen receptor T cell therapy using nanobodydisplaying lentiviral vectors
1/11/24 → 31/10/25
Project: Fundamental
-
OZR4288: Financiering MZW OZR: RAPTOR: Rapid Analysis and production of Proteins for clinical Translation using biacORe and bioreactOR systems.
Devoogdt, N., Hernot, S., De Groof, T., Ballet, S., Stijlemans, B., Massie, A., Rooman, I., Keyaerts, M., Raes, G., De Kock, J., Breckpot, K., De Veirman, K. & Caveliers, V.
24/04/24 → 24/04/28
Project: Fundamental
-
OZR4286: Financiering MZW OZR: DELI-SORT: MACSQuant® Tyto for sterile DELicate Immune cells SORTing
Laoui, D., Vanginderachter, J. A., Magez, S., Tuyaerts, S., Fioravanti, A., Devoogdt, N., Van der Henst, C., Raes, G., Stijlemans, B., Hadadi, E., De Trez, C., Ruytinx, J., Brunner, J., De Groof, T. & De Veirman, K.
24/04/24 → 24/04/28
Project: Fundamental
-
SRP95: Exploiting Peptides as Protein Binders, Modulators, Inhibitors and Biomaterials for Imaging and Therapy [Exploit-PeptIT]
Ballet, S., Caveliers, V., Hernot, S., Versées, W., Devoogdt, N. & Covens, P.
1/03/24 → 28/02/29
Project: Fundamental
Research output
-
Advancements in Nuclear Imaging Using radiolabeled Nanobody tracers to support Cancer Immunotherapy
Zeven, K., Lauwers, Y., De Mey, L., Debacker, J., De Pauw, T., De Groof, T. & Devoogdt, N., 26 Aug 2024, In: Immunotherapy Advances. 4, 1, 11 p., Itae006.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
Anti-Idiotypic VHHs and VHH-CAR-T Cells to Tackle Multiple Myeloma: Different Applications Call for Different Antigen-Binding Moieties
Hanssens, H., Meeus, F., Gesquiere, E. L., Puttemans, J., Vlaeminck, Y. D., Veirman, K. D., Breckpot, K. & Devoogdt, N., 22 May 2024, In: International Journal of Molecular Sciences. 25, 11, 16 p., 5634.Research output: Contribution to journal › Article › peer-review
Open AccessFile -
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Vandewalle, N., Satilmis, H., Verheye, E., Fan, R., Wang, Y., De Groof, T., Bridoux, J., kerre, T., De Beule, N., De Becker, A., De Bruyne, E., Menu, E., Vanderkerken, K., Breckpot, K., Devoogdt, N. & De Veirman, K., 15 Apr 2024, In: Theranostics. 14, 7, p. 2656-2674 19 p.Research output: Contribution to journal › Article › peer-review
Open AccessFile1 Citation (Scopus)1 Downloads (Pure) -
Efficient α and β- radionuclide therapy targeting fibroblast activation protein-α in an aggressive preclinical mouse tumour model
Ceuppens, H., Pombo Antunes, A. R., Navarro, L., Ertveldt, T., Berdal, M., Nagachinta, S., De Ridder, K., Lahoutte, T., Keyaerts, M., Devoogdt, N., Goyvaerts, C., D'Huyvetter, M. & Breckpot, K., 6 Sep 2024, In: European Journal of Nuclear Medicine and Molecular Imaging.Research output: Contribution to journal › Article › peer-review
-
Generation and Characterization of Novel Pan-Cancer Anti-uPAR Fluorescent Nanobodies as Tools for Image-Guided Surgery
Mateusiak, Ł., Floru, S., De Groof, T. W. M., Wouters, J., Declerck, N. B., Debie, P., Janssen, S., Zeven, K., Breckpot, K., Puttemans, J., Vincke, C., Devoogdt, N. & Hernot, S., Aug 2024, In: Advanced Science. 11, 30, 11 p., e2400700.Research output: Contribution to journal › Article › peer-review
Open Access1 Citation (Scopus)
Prizes
-
Alavi-Mandell Award from Journal of Nuclear Medicine
Krasniqi, A. (Recipient), D'Huyvetter, Matthias (Recipient), Devoogdt, Nick (Recipient) & Keyaerts, Marleen (Recipient), 16 Apr 2019
Prize: Prize (including medals and awards)
-
Best Poster Presentation
Vandewalle, Niels (Recipient), Menu, Eline (Recipient), De Bruyne, Elke (Recipient), De Veirman, Kim (Recipient), Breckpot, Karine (Recipient) & Devoogdt, Nick (Recipient), 2 Feb 2024
Prize: Prize (including medals and awards)
-
Certificat of Young Speaker Award
Lecocq, Q. (Recipient), Broos, K. (Recipient), Bridoux, Jessica (Recipient), Raes, Geert (Recipient), Xavier, C. (Recipient), Devoogdt, Nick (Recipient), Keyaerts, Marleen (Recipient) & Breckpot, Karine (Recipient), 1 Feb 2019
Prize: Prize (including medals and awards)
File -
Development of a nanoCAR-T cell approach for the treatment of multiple myeloma
Hanssens, Heleen (Recipient), Devoogdt, Nick (Recipient), De Veirman, Kim (Recipient) & Breckpot, Karine (Recipient), 15 Dec 2021
Prize: Fellowship awarded competitively
-
Development of a radiotracer and small protein inhibitor against the novel immune checkpoint TIGIT
Zeven, Katty (Recipient), Devoogdt, Nick (Recipient) & Breckpot, Karine (Recipient), 15 Dec 2020
Prize: Fellowship awarded competitively
Activities
-
Evaluation of nanobody-scaffolds as nuclear imaging tracers for noninvasive detection of the next generation immune checkpoint TIGIT
Katty Zeven (Speaker), Herlinde Dierick (Contributor), Matthijs Sevenois (Contributor), Henri Vincent Baudhuin (Contributor), Jessica Bridoux (Contributor), Laurent Navarro (Contributor), Timo De Groof (Contributor), Geert Raes (Contributor), Karine Breckpot (Contributor) & Nick Devoogdt (Contributor)
26 Aug 2024 → 30 Aug 2024Activity: Talk or presentation › Talk or presentation at a conference
-
Fully automated production of [18F]FB-labeled single-domain antibodies: the immune-checkpoint TIGIT for PET imaging
Herlinde Dierick (Speaker), Katty Zeven (Contributor), Laurent Navarro (Contributor), Tony Lahoutte (Contributor), Nick Devoogdt (Contributor), Vicky Caveliers (Contributor) & Jessica Bridoux (Contributor)
18 Apr 2024 → 21 Apr 2024Activity: Talk or presentation › Talk or presentation at a conference
-
The use of a CD163-specific nanobody-based immunotracer as a clinical imaging agent to study immunosuppressive tumor-associated macrophages
Yoline Lauwers (Contributor), Timo De Groof (Contributor), Maral Emami (Contributor), Cecile Vincke (Speaker), Jolien Van Craenenbroeck (Contributor), Geert Raes (Contributor), Jo Van Ginderachter (Contributor) & Nick Devoogdt (Contributor)
11 Mar 2024 → 13 Mar 2024Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
Nanobody-based Panx1 channel inhibitors reduce inflammation in acute liver injury
Daan Peeters (Presenter), Timo De Groof (Contributor), Prashant Kadam (Contributor), Brenda R. Kwak (Contributor), Serge Muyldermans (Contributor), Nick Devoogdt (Contributor), Raf Van Campenhout (Contributor) & Mathieu Vinken (Contributor)
7 Oct 2024Activity: Talk or presentation › Talk or presentation at a workshop/seminar
-
AXL-specific single domain antibodies show diagnostic potential and anti-tumor activity in Acute Myeloid Leukemia
Niels Vandewalle (Presenter), Hatice Satilmis (Contributor), Emma Verheye (Contributor), Yanmeng Wang (Contributor), Timo De Groof (Contributor), Nathan De Beule (Contributor), Tessa kerre (Contributor), Nathan De Beule (Contributor), Ann De Becker (Contributor), Elke De Bruyne (Contributor), Eline Menu (Contributor), Karin Vanderkerken (Contributor), Karine Breckpot (Contributor), Nick Devoogdt (Contributor) & Kim De Veirman (Contributor)
12 Mar 2024Activity: Talk or presentation › Talk or presentation at a conference
Press/Media
-
VUB team develops breakthrough nanobody technology against liver inflammation
Raf Van Campenhout, Mathieu Vinken, Nick Devoogdt & Timo De Groof
8/12/23
1 item of Media coverage
Press/Media: Other
-
Betaalbare kankerimmunotherapie
Karine Breckpot, Nick Devoogdt, Yannick De Vlaeminck & Fien Meeus
8/02/22
1 item of Media coverage
Press/Media: Research
-
VUB-onderzoekers en start-up Esobiotec streven naar betaalbare kankerimmunotherapie
Karine Breckpot, Nick Devoogdt, Yannick De Vlaeminck & Fien Meeus
31/01/22
1 Media contribution
Press/Media: Research
-
VUB-onderzoekers en start-up Esobiotec willen kankerimmunotherapie betaalbaarder maken
Karine Breckpot, Nick Devoogdt, Fien Meeus & Yannick De Vlaeminck
31/01/22
1 item of Media coverage
Press/Media: Research
-
EsoBiotec ready to transform cell therapy cancer treatments
Karine Breckpot & Nick Devoogdt
30/09/21
1 item of Media coverage
Press/Media: Research
Thesis
-
Assessment of antigen-binding domain parameters important for adequate CAR-T-cell activation: evaluating different SLAMF7-targeting nanobodies.
Author: Meeus, F., Hanssens, H., De Veirman, K. & Devoogdt, N., 19 Jun 2020Supervisor: Hanssens, H. (Advisor)
Student thesis: Master's Thesis
-
Bead based immunoassay of HER2 ECD domain using nanobodies
Author: Adaga, E., Muyldermans, S., De Pauw, P. & Devoogdt, N., 1 Sep 2015Student thesis: Master's Thesis
-
CD20 Nb TRNT: targeted radionuclide therapy of non-hodgkin-lymphoma with anti-CD20 nanobodies
Author: Devoogdt, N., D'Huyvetter, M. & Tavernier, J., 24 May 2019Student thesis: Doctoral Thesis
-
Characterization of CD69-targeting nanobodies as immunotracers
Author: Ndini, T., Van Ginderachter, J., Devoogdt, N., Vincke, C. & De Groof, T., Sep 2021Student thesis: Master's Thesis
-
Controlled and covalent bioconjugation of materials with site-specifically functionalized nanobodies for advanced medical diagnostics
Author: Ta, T., Adriaensens, P., Guedens, W. & Devoogdt, N., Sep 2016Student thesis: Doctoral Thesis